The second joint meeting between the Royal Society of Medicine Forum on Clinical Haemorheology and La Societe Francaise D'Hemorheologie Clinique took place in London on the 13 and 14 September 1990. It was a lively meeting with 43 registrants and 28 oral presentations. The meeting comprised two general themes -haemorheology in obstetrics/neonatology and the importance of leukocytes in both rheology and thrombosis. There was also a liberal sprinkling of free communications.
Hyperviscosity of the blood is reported in 1-5% of all infants and is associated with clinical complications in 50% of those affected'. These clinical problems include cardiorespiratory failure, hyperbilirubinaemia, convulsion and neurological damage'', Mr P Buchan (St James' University Hospital, Leeds) began the first special session with an overview of the interrelationship between haemorheology in obstetrics and neonatology. Many of the haemorheological abnormalities of the neonate are themselves a reflection of irregularities in the maternal circulation. Hence the adequacy of placental flow, on both maternal and fetal sides of the placenta, is critical for fetal growth and development and abnormal haemorheology seems to be the final common pathway for fetal intrauterine growth retardation in many pathological pregnancies'', Common causes of retarded fetal growth are constitutional factors, chronic infection and intrauterine malnutrition. Malnutrition usually results from placental insufficiency following infections, gestosis or maternal smoking. Growth retardation of the fetus leads to an increase in haematocrit and blood viscosity and a decrease in red cell filterability in the neonate. Smoking affects red cell filterability during pregnancy with no other gross haemorheological disturbances. Haemorheological differences are much more pronounced in the infants of smoking mothers. Hence whole blood viscosity is raised due to an increase in haematocrit and a decreased red cell filterability". The speaker drew attention to an interesting point that haemorheological problems of this sort, transferred from the mother to the infant, can be carried through to adulthood. There is a relationship between the incidence ofintrauterine growth retardation and hypertension in later life -the fetus is indeed the 'father of the man'. Diabetic adults have a higher blood viscosity than normal due largely to an increase in plasma fibrinogen and acute phase globulins. The resulting decrease in maternal circulation through the placenta leads to compensatory changes in the fetal blood. Hence infants of diabetic mothers acquire haemorheological problems due largely to an elevated haematocrit and possibly plasma viscosityv", They also have more rigid red blood cells with less elastic membranes'. Mr J Onwude (St James' University Hospital, Leeds), during the same presentation, described new data from a study of 20 infants of insulin-controlled diabetic mothers and 30 infants of normal mothers within the same age range. The results confirmed an increased haematocrit and blood, but not plasma, viscosity and demonstrated a 12.5% reduction in red cell filterability in infants of diabetic mothers.
A previous report of a meeting of this forum described how the viscosity of neonatal blood, when measured at a standard haematocrit, is lower than that of adult blood", This is attributed to the lower plasma viscosity due to a decreased concentration of plasma proteins. The major effect is therefore seen at low shear rates when red cell aggregation, enhanced by fibrinogen, dominates viscosity. Dr M W Rampling (St Mary's Hospital, London) delivered a useful review of this data and also provided new detail. The aggregation of neonatal cells is lower than adult cells in certain artificial media" and hence the cells must be inherently different. Nevertheless their aggregating properties are the same in adult fibrinogen but that of the neonatal cells is reduced when measured in neonatal plasma. The speaker therefore argued that the major difference in aggregating properties of neonatal cells in autologous blood can be attributed to plasma proteins such as fibrinogen and immunoglobulins. There is an inverse relationship between the sialic acid content of fibrinogen and the gestational age of the infant and this trend is paralleled by the haemorheological differences between neonatal and adult blood. Hence the chemical nature of the fibrinogen, as well as its concentration, is an important determinant of red cell aggregation in neonates. Neonatal blood circulation is subjected to poor autoregulation and is characterized by high flow at low pressure and low peripheral resistance. It is therefore vulnerable to changes in viscosity and the contribution of neonatal plasma to a reduction in blood fluidity may be important, under these circumstances, in dealing with the frequently high haematocrits found at birth.
Interest in the rheology of leukocytes continues to expand with a keen regard for their extreme sensitivity to environmental changes. This aspect, although a practical problem, may well be valuable in assessing the extent of ischaemic disorders in the microcirculation or any other factors that will lead to leukocyte activation in vivo. The activation of the cells can be detected by changes in their filterability", However care must be taken to avoid such changes in cell activation, and hence filterability, in uitro", It is therefore evident that rheologists, who measure the properties of leukocytes, require a broader knowledge of the physiological function and biochemical characteristics of the different types of white blood cells. An important part of this meeting was therefore devoted to broader aspects of leukocyte function. Professor J L Wautier (Hopital Lariboisiere, Paris) gave a detailed review of the involvement of monocytes in blood coagulation. This subpopulation of leukocytes has many features The Royal Society of Medicine in common with endothelial cells -they produce procoagulant activities, when activated, and possess membrane receptors for clotting factors such as Factor X and Factor Xa. Leukocytes may participate in coagulation by (1) producing procoagulant activity, (2) by providing an adsorbing surface to increase the rate of the coagulation cascade or (3) secreting cytokines that can stimulate cells to produce procoagulant activity. Hence, interleukin 1 or tumour necrosis factor-a, produced by monocytes, stimulate endothelial cells to secrete procoagulant activity. Endotoxins from meningococcal infections may stimulate the activation ofmonocytes and, in experimental animals, this event coincides with secretion of tissue necrosis factor (TNF) and a decrease in blood pressure. The speaker pointed to a strong relationship between coagulation, cytokine production and septic shock. Dr J F Schved (Hopital de Nimes, Paris) described the effectof plasma factors on the stimulation of monocyte procoagulant activity by endotoxin or TNF. Plasma from 12 patients, with Lupus Anticoagulant, were compared with that from suitably matched controls and found to enhance the production ofprocoagulant activity by the stimulated leukocytes. This theme continued with three papers dealing with the effect of heparin on rheological and coagulant activities of blood cells. Dr G Freyburger (Hopital Cardiologie, Pessac) described the modification of polymorphonuclear (PMN) functions by incubation with different heparins in vitro. The various heparins inhibit the release of oxygen-derived free radicals and phagocytosis but increase chemotaxis. At sufficiently high doses these compounds seem to act as 'buffers' of LTB4 production by granulocytes -ie they stimulate low producers and inhibit high producers. This buffering action is correlated with the charge density, molecular weight and concentration of the drugs. Dr P Nguyen (Laboratoire d'Hemorheologie, Heims) reported that therapeutic concentrations of a number of heparins had no effect on standard PMN functions either in vitro or when tested ex vivo in elderly patients undergoing prophylaxis with low molecular weight heparins. In this study, a small decrease was recorded in the shear rate required to dissociate red cell aggregates in the presence of heparin in vitro. This decrease in red cell aggregation by low molecular weight heparin, was also reported by Mr N V Wilson (King's College Hospital, London) in a controlled clinical trial in patients with peripheral vascular disease. Patients receiving the drug experienced a small decrease in blood viscosity that was partly related to the effect on red cell aggregation. These changes were paralleled by an increase in blood flow in the ischaemic limb. However, the increased flow persisted after blood rheology had returned to normal.
Among a number of interesting free communications, Mr B Cooke (University of Birmingham Medical School) described an important new technique for assessing the contribution of the vascular endothelial cells to the flow of blood through the microcirculation. The adhesion of platelets, leukocytes and erythrocytes Journal of the Royal Society of Medicine Volume 84 April 1991 241 are believed to make a significant contribution to vascular occlusion in ischaemic heart disease-P. Erythrocyte adhesion to the endothelium has also been described in sickle cell disease!'. Mr Cooke presented a new approach to measuring the adherence of erythrocytes, infected with P. falciparium, to cultured human umbilical vein endothelial cells. The described adaptation turns a 'static' assay into a kinetic one that can assess the strength of adhesion by estimating the stress required to detach adhered erythrocytes from the endothelial cells. The cultured cells are grown on a glass slide that forms the base of a rectangular channel through which a suspension of erythrocytes can be drawn at a controlled rate. In this apparatus, the level of non-parasitized cell adhesion is low but infected cells adhere strongly and some can withstand shear stresses of an order of magnitude higher than those encountered in the venular circulation. This will undoubtedly prove a valuable tool for investigating the importance of cytoadherence in the development of ischaemic complications in malaria. It also has wider application in general studies of blood cell interactions with the vascular endothelium and the effect of drugs on this process.
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